Clarke David M, McLeod Janet E, Smith Graeme C, Trauer Tom, Kissane David W
Monash University, Department of Psychological Medicine, Monash Medical Centre, Melbourne, Victoria, Australia.
J Palliat Care. 2005 Autumn;21(3):173-9.
Although their disease processes and treatments are different, patients with motor neurone disease (MND) and those with late-stage cancer share a common situation--one in which the quality of life, rather than a cure, becomes the focus of care. We report here a comparison of 126 patients with MND and 125 with metastatic cancer on a range of physical and psychosocial measures. Compared to cancer patients, MND patients were younger, had greater social contacts, but were more physically impaired. Cancer patients had more pain and were on more medication (opioids, steroids, and analgesics). Although the Beck depression scores were similar in both groups, MND patients had significantly higher scores for demoralization, hopelessness, and suicidal ideation. Cancer patients, on the other hand, scored significantly higher on anhedonia. We suggest this difference in the quality of depression represents a difference in illness experience of the two groups and has relevance for the ways we treat depression in the medically ill.
尽管运动神经元病(MND)患者和晚期癌症患者的疾病进程及治疗方法不同,但他们面临着共同的情况——生活质量而非治愈成为护理的重点。我们在此报告了126例MND患者和125例转移性癌症患者在一系列身体和心理社会指标上的比较情况。与癌症患者相比,MND患者更年轻,社交联系更多,但身体损伤更严重。癌症患者疼痛更多,服用的药物(阿片类药物、类固醇和镇痛药)更多。尽管两组的贝克抑郁量表得分相似,但MND患者在士气低落、绝望和自杀意念方面的得分显著更高。另一方面,癌症患者在快感缺失方面的得分显著更高。我们认为这种抑郁质量的差异代表了两组患者疾病体验的差异,并且与我们治疗患病者抑郁的方式相关。